JP Morgan Chase’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-25,000
Closed -$5.09M 7564
2024
Q2
$5.09M Buy
+25,000
New +$5.09M ﹤0.01% 3022
2023
Q1
Sell
-815
Closed -$165K 7000
2022
Q4
$165K Buy
+815
New +$159K ﹤0.01% 5130
2016
Q4
Sell
-233
Closed -$27K 5071
2016
Q3
$27K Buy
+233
New +$27.5K ﹤0.01% 4141

Other funds holding LH

JP Morgan Chase's LH Position: Q1 2026 in Review

JP Morgan Chase increased its Labcorp (LH) stake by 19% in Q1 2026, buying an estimated $66.5M and bringing the position to 1,532,723 shares worth $404M. The position accounts for 0.03% of the portfolio, ranked #466.

JP Morgan Chase first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $498M in Q4 2022. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • JP Morgan Chase held 1,532,723 shares of Labcorp worth $404M as of Q1 2026.
  • JP Morgan Chase bought 245,546 Labcorp shares in Q1 2026, an estimated $66.5M.
  • Labcorp made up 0.03% of JP Morgan Chase's portfolio in Q1 2026, its #466 holding.
  • JP Morgan Chase first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Labcorp position peaked at $498M in Q4 2022.
  • 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.